Moderna (MRNA) is up around 16% today after reporting better-than-expected quarterly earnings and revenue. The company saw its revenue jump 9% year over year to $4.7 billion, with the vast majority of sales, $4.5 billion, coming from its COVID-19 vaccine.
MRNA now sells for around 7 times forward earnings, less than half of the valuation of the S&P 500.
I am recommending a silly put to sell to reduce our net debit on the position.
You can enter today’s trade even if you were not in the previous one. Just be aware that we will be managing and tracking it based on the ongoing position.
Current Stock Price: $186.83
Net Debit: $3.29
Action: Sell to open the MRNA Aug Monthly (8/19) 165 Put for around $2.63, but adjust as needed to sell a put today
New Net Debit: $0.66